Vanda Pharmaceuticals Inc.
- VNDA
- NASDAQ
- Biotechnology
- Sleep Disorder Treatment
- Antipsychotic Drugs
$4.03
Today −4.95%Quote Oct 16, 2026, 08:00 PM UTC
−21.14%over the last month
Max drawdown −22.6%From 1-month high −22.6%3 months −24.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$243.7M
Quote Oct 16
Next earnings
Nov 4
Expected, not confirmed
Analyst target
$15.50
+284.6% from here
Floor
$4.01
0.6% below price
Where the price sits
19 analysts
Analyst range, low to high
$10.00$21.00
- Price $4.03
- Resistance $4.11
- Consensus $15.50
The price is just above its floor and right under resistance. Analysts' average target sits about 285% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VNDAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $50.5M
- Fanapt$36.0M71.2%
- Hetlioz$5.6M11.0%
- Other / not reported$9.0M17.7%
Industry
Biotechnology
Employees
533